Merit Medical Systems, Inc.
Merit Medical Systems, Inc. (Nasdaq: MMSI) designs, manufactures and markets medical devices used in interventional, diagnostic and therapeutic procedures, including cardiology, radiology, oncology, critical care and endoscopy. Its customers include hospitals, physicians, technicians, nurses and other medical-device… From the company’s description.
Over the twelve months to Sep 30, 2026, Merit Medical Systems, Inc. reported revenue of $1.61B, up 9.1% from a year earlier, and net income of $160.12M. Its operating margin was 13.5%, and operations generated $273.74M in cash. In fiscal 2025, it reported revenue of $1.52B, up 11.8% from fiscal 2024, and net income of $128.49M.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Merit Medical Systems, Inc. does
In the company’s own words
Merit Medical Systems, Inc. (Nasdaq: MMSI) designs, manufactures and markets medical devices used in interventional, diagnostic and therapeutic procedures, including cardiology, radiology, oncology, critical care and endoscopy. Its customers include hospitals, physicians, technicians, nurses and other medical-device manufacturers. Merit operates through two segments, cardiovascular and endoscopy; cardiovascular includes peripheral and cardiac intervention, oncology, custom procedural solutions and OEM products, while endoscopy serves gastroenterology and pulmonary procedures. Products include vascular access devices, catheters, guide wires, biopsy systems, embolotherapy products, procedural kits, esophageal and airway stents, and components and finished devices made for OEM customers. Its brands include Prelude, SCOUT, Embosphere, Aspira, EsophyX and AERO. Merit sells through direct sales teams and distributors, with U.S. sales representing 60% of net sales in 2025. The company has eleven manufacturing facilities worldwide and traces its origins to a 1987 business focused on plastic injection and insert molding. Its website is www.merit.com.
Company details
- Sector
- Health Care
- Industry (SIC)
- Surgical & Medical Instruments
- Headquarters
- SOUTH JORDAN, UT
- Fiscal year end
- December
- CIK
- 856982
- SIC
- 3841
Financial performance, year by year
Fiscal 2011–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Merit Medical Systems, Inc. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · Merit Medical Systems, Inc.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Merit Medical Systems, Inc.’s bonds, as funds hold them
Funds report holding 1 issues of Merit Medical Systems, Inc.’s debt, $162.88M at market value — what funds hold, not the company’s total debt. Weighted-average coupon 3.00%, maturing 2029 to 2029.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Merit Medical Systems, Inc. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Merit Medical Systems, Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Merit Medical Systems, Inc.'s last four quarterly filings that the numbers alone won't show?”